Novocure's stock jumps 37% on FDA approval for its pancreatic cancer device. High hopes for patient returns.
Microsoft's $1B OpenAI bet now worth $135B, yielding $7.6B net income. High risk, high reward!
GOOGL's 745% 10-yr return shines despite AI selloff. Strong cash flow & 16.6% revenue growth outlook at 22x forward earnings.
Bitcoin plunges 40%, losing its 'digital gold' narrative. Gold & stablecoins now win macro & payments.
SoftBank's proposed 9.2 GW Ohio gas plant faces climate risk, potentially emitting 19.4M tons CO2/yr.
TGT surges 19% on strong returns; AAPL calls cheap on downside risk; ORCL shows calm skew despite drops.
Housing costs drag down consumer sentiment despite low inflation & unemployment. Borrowing rates remain high.